COOPER COMPANIES, INC. News
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
see moreCOOPER COMPANIES, INC. Market News
25 May at 04:21
COO: Strong Q1, Board Upgrade, Buyback Momentum Up
- CooperCompanies (COO) posted solid fiscal Q1 2026 results, executed meaningful share repurchases and added veteran executive Paul Keel to the board. With $1.024B revenue, improved margins and $873.9M remaining buyback capacity, investor focus shifts to the June 4 Q2 earnings call for confirmation of sustained momentum across CooperVision and CooperSurgical.
18 May at 04:21
CooperCompanies: Keel Joins Board; June 4 Earnings
CooperCompanies (COO) named Envista CEO Paul Keel to its board effective July 1 and set its Q2 2026 earnings release for June 4. Recent disclosure highlights solid trailing financials, a modest short interest decline, analyst buy consensus, and refreshed guidance after a better-than-expected quarter—concrete items investors will watch ahead of the call.
11 May at 04:22
CooperCompanies Board Adds Paul Keel; Q2 Wed 6/4AM
CooperCompanies announced Paul Keel’s board appointment effective July 1 and set a Q2 earnings webcast for June 4. Recent 13F filings show mixed institutional moves: ProShares trimmed its position while Capital Group’s ETF materially increased exposure — a split that underscores investor differentiation ahead of the webcast.
04 May at 04:21
CooperCompanies (COO): Q2 Call Sets Stock Focus Up
CooperCompanies (COO) announced its Q2 2026 earnings webcast for June 4, 2026. With no other material news in the last week, investors are focused on segment organic growth, margin trends, and capital allocation after a strong Q1 that raised guidance. This article summarizes the latest facts, what to watch on the call, and practical investor takeaways.
27 Apr at 04:21
CooperCompanies: ESG Push, Guidance Lift Plus Debt
CooperCompanies (COO) moved the needle this week with a high-profile sustainability initiative from CooperVision, continued strong fiscal guidance from Q1, and meaningful financing flexibility after a recent term-loan amendment. These concrete developments — not speculation — shape near-term investor expectations for the vision-care and women’s health leader.
20 Apr at 04:21
COO: Q1 Beat and Japan MiSight Launch
CooperCompanies reported a solid Q1 FY2026 with revenue growth, stronger EPS, meaningful free cash flow and a $92.5M buyback. Strategic wins — notably the rollout of MiSight® 1 day in Japan and the MADE BETTER™ sustainability initiative — reinforce CooperVision’s premium push and support CooperCompanies’ upgraded FY2026 guidance.
13 Apr at 04:21
CooperCompanies Q1 Upside, Activists Demand Split!
CooperCompanies reported solid Q1 results and a large share-repurchase while activists press for a split of CooperVision and CooperSurgical. Operational strain at CooperSurgical, including a sharp drop in operating income and IT-control weaknesses, keeps strategic change and governance front-and-center for investors.